ArticleBiomarker research2022

Blood-based tumour mutation index act as prognostic predictor for immunotherapy and chemotherapy in non-small cell lung cancer patients.

Jun Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.